vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and Idaho Strategic Resources, Inc. (IDR). Click either name above to swap in a different company.
Idaho Strategic Resources, Inc. is the larger business by last-quarter revenue ($14.6M vs $13.8M, roughly 1.1× FENNEC PHARMACEUTICALS INC.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs -34.7%, a 99.0% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs 73.8%). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Idaho Strategic Resources, Inc.IDREarnings & Financial Report
Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.
FENC vs IDR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $14.6M |
| Net Profit | $-4.8M | $9.4M |
| Gross Margin | — | 68.5% |
| Operating Margin | -18.5% | 62.4% |
| Net Margin | -34.7% | 64.3% |
| Revenue YoY | 73.8% | 92.0% |
| Net Profit YoY | -141.1% | 220.6% |
| EPS (diluted) | $-0.17 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $14.6M | ||
| Q3 25 | $12.5M | $11.1M | ||
| Q2 25 | $9.7M | $9.5M | ||
| Q1 25 | $8.8M | $7.3M | ||
| Q4 24 | $7.9M | $7.6M | ||
| Q3 24 | $7.0M | $6.2M | ||
| Q2 24 | $7.3M | $6.1M | ||
| Q1 24 | $25.4M | $5.9M |
| Q4 25 | $-4.8M | $9.4M | ||
| Q3 25 | $-638.0K | $3.0M | ||
| Q2 25 | $-3.2M | $2.8M | ||
| Q1 25 | $-1.2M | $1.6M | ||
| Q4 24 | $-2.0M | $2.9M | ||
| Q3 24 | $-5.7M | $1.6M | ||
| Q2 24 | $-5.6M | $2.2M | ||
| Q1 24 | $12.8M | $2.2M |
| Q4 25 | — | 68.5% | ||
| Q3 25 | — | 63.6% | ||
| Q2 25 | — | 57.8% | ||
| Q1 25 | — | 50.8% | ||
| Q4 24 | — | 53.3% | ||
| Q3 24 | — | 48.7% | ||
| Q2 24 | — | 50.2% | ||
| Q1 24 | — | 48.1% |
| Q4 25 | -18.5% | 62.4% | ||
| Q3 25 | -1.5% | 23.4% | ||
| Q2 25 | -28.3% | 26.6% | ||
| Q1 25 | -9.2% | 19.3% | ||
| Q4 24 | -11.8% | 36.2% | ||
| Q3 24 | -74.6% | 23.4% | ||
| Q2 24 | -69.4% | 34.2% | ||
| Q1 24 | 54.2% | 36.3% |
| Q4 25 | -34.7% | 64.3% | ||
| Q3 25 | -5.1% | 26.8% | ||
| Q2 25 | -32.7% | 29.2% | ||
| Q1 25 | -13.3% | 22.1% | ||
| Q4 24 | -25.0% | 38.5% | ||
| Q3 24 | -82.2% | 25.8% | ||
| Q2 24 | -76.5% | 35.2% | ||
| Q1 24 | 50.6% | 36.8% |
| Q4 25 | $-0.17 | $0.62 | ||
| Q3 25 | $-0.02 | $0.20 | ||
| Q2 25 | $-0.11 | $0.20 | ||
| Q1 25 | $-0.04 | $0.12 | ||
| Q4 24 | $-0.02 | $0.21 | ||
| Q3 24 | $-0.21 | $0.12 | ||
| Q2 24 | $-0.20 | $0.17 | ||
| Q1 24 | $0.41 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | — |
| Total DebtLower is stronger | — | $2.3M |
| Stockholders' EquityBook value | $35.5M | $108.2M |
| Total Assets | $70.6M | $116.2M |
| Debt / EquityLower = less leverage | — | 0.02× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | — | ||
| Q3 25 | $21.9M | — | ||
| Q2 25 | $18.7M | — | ||
| Q1 25 | $22.7M | — | ||
| Q4 24 | $26.6M | — | ||
| Q3 24 | $40.3M | — | ||
| Q2 24 | $43.1M | $6.3M | ||
| Q1 24 | $51.2M | $5.3M |
| Q4 25 | — | $2.3M | ||
| Q3 25 | $19.4M | $3.0M | ||
| Q2 25 | $19.4M | $3.3M | ||
| Q1 25 | $19.4M | $3.7M | ||
| Q4 24 | $19.3M | $1.7M | ||
| Q3 24 | $32.1M | $2.9M | ||
| Q2 24 | $31.8M | $2.7M | ||
| Q1 24 | $31.3M | $3.3M |
| Q4 25 | $35.5M | $108.2M | ||
| Q3 25 | $-4.5M | $74.3M | ||
| Q2 25 | $-7.5M | $49.3M | ||
| Q1 25 | $-5.9M | $39.8M | ||
| Q4 24 | $-5.9M | $37.7M | ||
| Q3 24 | $-5.2M | $33.1M | ||
| Q2 24 | $-1.4M | $25.4M | ||
| Q1 24 | $3.0M | $21.6M |
| Q4 25 | $70.6M | $116.2M | ||
| Q3 25 | $49.3M | $83.1M | ||
| Q2 25 | $44.9M | $57.7M | ||
| Q1 25 | $46.4M | $48.1M | ||
| Q4 24 | $44.9M | $44.0M | ||
| Q3 24 | $58.9M | $40.8M | ||
| Q2 24 | $63.2M | $32.2M | ||
| Q1 24 | $69.2M | $28.7M |
| Q4 25 | — | 0.02× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | 10.40× | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $10.7M |
| Free Cash FlowOCF − Capex | — | $8.2M |
| FCF MarginFCF / Revenue | — | 56.0% |
| Capex IntensityCapex / Revenue | — | 17.7% |
| Cash ConversionOCF / Net Profit | — | 1.15× |
| TTM Free Cash FlowTrailing 4 quarters | — | $12.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $10.7M | ||
| Q3 25 | $1.5M | $2.4M | ||
| Q2 25 | $-3.7M | $3.5M | ||
| Q1 25 | $-4.3M | $2.4M | ||
| Q4 24 | $-1.5M | $3.2M | ||
| Q3 24 | $-2.2M | $2.5M | ||
| Q2 24 | $-8.4M | $2.6M | ||
| Q1 24 | $39.0M | $2.6M |
| Q4 25 | — | $8.2M | ||
| Q3 25 | — | $709.8K | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $1.0M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $1.9M | ||
| Q2 24 | — | $2.4M | ||
| Q1 24 | — | $2.3M |
| Q4 25 | — | 56.0% | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | 26.5% | ||
| Q1 25 | — | 13.8% | ||
| Q4 24 | — | 28.0% | ||
| Q3 24 | — | 30.4% | ||
| Q2 24 | — | 38.7% | ||
| Q1 24 | — | 38.3% |
| Q4 25 | — | 17.7% | ||
| Q3 25 | — | 15.3% | ||
| Q2 25 | — | 10.8% | ||
| Q1 25 | — | 19.4% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 9.8% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | 5.5% |
| Q4 25 | — | 1.15× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.28× | ||
| Q1 25 | — | 1.50× | ||
| Q4 24 | — | 1.08× | ||
| Q3 24 | — | 1.56× | ||
| Q2 24 | — | 1.22× | ||
| Q1 24 | 3.04× | 1.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
